Summary of Purpose
Background: Unfractionated heparin (UFH) is a sulfated polysaccharide extracted from porcine intestinal mucosa that enhances the inhibitory activity of the natural anticoagulant antithrombin towards most activated clotting factors (F), particularly FXa and FIIa (thrombin) . Despite the growing interest for low molecular weight derivatives (LMWH), UFH is still widely used for different indications including...Read More →
The following dates are available for this trial. Trial information last updated on 12 March 2018.
|1 Mar 2018||1 Feb 2018||1 Oct 2018||30 Oct 2018||1 Mar 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Conditions See All